NGM Biopharmaceuticals
NGM
$1.54
Share price
0.00%
Change (1 day)
-53.89%
Change (1 year)
Categories
NGM Biopharmaceuticals (NGM) - Net assets
Net assets on the balance sheet as of December 2023 : $0.14 B
According to NGM Biopharmaceuticals's latest financial reports the company has $0.14 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
NGM Biopharmaceuticals - Net assets on balance sheet (from 2017 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $0.14 B | -42.73% |
| 2022-12-31 | $0.25 B | -22.67% |
| 2021-12-31 | $0.33 B | 19.86% |
| 2020-12-31 | $0.28 B | -15.32% |
| 2019-12-31 | $0.33 B | -405.67% |
| 2018-12-31 | $-0.11 B | -10.57% |
| 2017-12-31 | $-0.13 B | 5.14% |
| 2016-12-31 | $-0.12 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | $1.25 B | 742.86% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | $6.01 M | -95.95% | 🇺🇸 USA |